Short description:
Precision Medicines for Brain Diseases
Drug notes:
NMRA-511 Clin1 anxiety; NMRA-M4R Clin0 neuropsychiatric disorders; NMRA-GRIN2A Clin0 neuropsychiatric disorders; 3 programs RD/Clin0 neurodegenerative diseases
Long description:
Neumora Therapeutics is a biopharmaceutical company founded to address the global brain disease crisis and improve patient lives through the development of targeted and effective neurodegenerative and neuropsychiatric therapies. Neumora’s therapeutics are aimed to target relevant pathways across various CNS diseases. They also leverage a precision medicine approach to identify patient populations of interest. Their research investigates the mechanisms of action behind major depressive disorder, schizophrenia, bipolar depression, Alzheimer’s, ALS, and Parkinson’s disease. Utilizing their precision medicine approach, Neumora is committed to discovering novel therapeutic targets and developing effective and meaningful therapies.
Jobs:
Vice President, Clinical Quality United States|3 days ago
CMC Project Manager Massachusetts, United States|4 days ago
Director, Clinical Quality Assurance (cQA) United States|25 days ago
Senior Director, Health Economics Outcomes Researc... United States|25 days ago